M. Vallverdú Vidal-rekin lankidetzan egindako argitalpenak (12)

2023

  1. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  2. One-year mortality after ICU admission due to COVID-19 infection

    Intensive Care Medicine

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. Entamoeba histolytica liver abscess case: Could stool PCR avoid it?

    Diagnosis, Vol. 7, Núm. 1, pp. 69-73

2017

  1. Isolated renal mucormycosis in a critically ill patient

    Revista Iberoamericana de Micologia

2015

  1. Characteristics of isolated multiresistant bacteria according germ, location and “Zero Resistance” criteria

    Intensive Care Medicine Experimental

  2. Risk factors for colonization and infection by multiresistant bacteria

    Intensive Care Medicine Experimental

2002

  1. Community-acquired pneumonia: Usefulness of clinical presentation in the selection of antibiotic treatment

    Medicina Clinica, Vol. 119, Núm. 17, pp. 641-643

1999

  1. Neumonía adquirida en la comunidad: Impacto de la utilización de una estrategia terapéutica basada en la mortalidad a corto plazo

    Medicina Clinica, Vol. 113, Núm. 3, pp. 85-88

1993

  1. DISECCION AGUDA DE LA AORTA TORACICA: PRESENTACION CLINICA COMO CUADRO DE SHOCK SIN DOLOR

    Medicina Intensiva, Vol. 17, Núm. 2, pp. 122-124